SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TLT.v
TLT.V 0.160+3.2%Nov 26 3:57 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: 3bar12/30/2019 1:02:58 PM
   of 1868
 
You do not have to understand the science here or the devices to understand results from Phase 1 . 9 patients who had tried all treatments , refused to have their bladders cut out and were to die if this treatment did not work .

How dire is that ?

It worked so well The FDA reduced the # needed to 6 . 3 at a minimal dose and 3 at a therapeutic dose to determine if the compound would make humans sick in any way . All patients experienced 100 % kill of cancer in the bladder on testing at 3 months with " NO " side effects .

Ding Dong Cancers Dead ! Phase 11 will clean up the lose ends from Phase 1 . 10 to 20 with similar results and we have " Fast Track " status for N. America and permission to roll out .

For Bladder Cancer only . Several others will be close behind . Unless !
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext